Docebo (DCBO) Cash & Equivalents (2019 - 2026)

Docebo (DCBO) has reported Cash & Equivalents for 8 consecutive years, with $63.2 million the latest figure, recorded in Q1 2026.

• Quarterly Cash & Equivalents fell 31.22% year-over-year to $63.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.2 million (down 31.22% YoY) and the FY2025 annual result came in at $74.0 million, down 19.99% from the prior year.
• Cash & Equivalents eased to $63.2 million in Q1 2026 per DCBO's latest filing, from $74.0 million in the prior quarter.
• Over the last five years, Cash & Equivalents for DCBO reached as high as $9.9 billion in Q3 2024 and fell as low as $63.2 million in Q1 2026.
• A 5-year average of $1.0 billion and a median of $170.6 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 66.73% — and 2024, when it surged 5696.14%.
• Year by year, Cash & Equivalents stood at $216.3 million in 2022, then tumbled by 66.73% to $72.0 million in 2023, then gained by 28.62% to $92.5 million in 2024, then dropped by 19.99% to $74.0 million in 2025, then retreated by 14.65% to $63.2 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $63.2 million, $74.0 million, and $5.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.